Wang Xiaolin

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Wang Xiaolin's trades of Revolution Medicines Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-17
PlS Planned sale
48,234 +29.2%
435.34
US$4,161,390 		48,234 +29.2% 435.34 US$4,161,390
2026-03-13 2026-03-16
PrS Proposed sale
9,358
91.93
US$96,784 		9,358 91.93 US$96,784
2023-03-21 2023-03-17
S Sale
85,946 -2.9%
23.00
US$972,894 		85,946 -2.9% 23.00 US$972,894
2022-12-21 2022-12-19
S Sale
708 -2.3%
22.94
US$16,241 		708 -2.3% 22.94 US$16,241
2022-09-21 2022-09-19
S Sale
735 -2.3%
19.04
US$13,996 		735 -2.3% 19.04 US$13,996
2022-06-22 2022-06-17
PlS Planned sale
665 -2.0%
17.75
US$11,803 		665 -2.0% 17.75 US$11,803
2022-03-21 2022-03-17
S Sale
240 -0.8%
18.61
US$4,467 		240 -0.8% 18.61 US$4,467
2021-12-21 2021-12-17
S Sale
257 -2.1%
24.41
US$6,273 		257 -2.1% 24.41 US$6,273
2021-06-22 2021-06-17
PlS Planned sale
243 -1.9%
34.12
US$8,291 		243 -1.9% 34.12 US$8,291